UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended: December 31, 2022 ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from _____to _____ Commission File Number: 001-37606 ANAVEX LIFE SCIENCES CORP. (Exact name of registrant as specified in its charter) Nevada 98-0608404 (State or ...

Anavex Life Sciences Corp. (NASDAQ:AVXL) Q3 2022 Results Conference Call August 9, 2022 4:30 PM ET Company Participants Clint Tomlinson - IR Dr. Christopher Missling - President and CEO Sandra Boenisch - Principal Financial Officer Conference Call Participants Soumit Roy - Jones Research Yun Zhong - BTIG Raghuram Selvaraju - H.C. Wainwright Clint Tomlinson Good afternoon. Welcome to the Anavex Life Sciences’ Fiscal 2022 Third Quarter Conference Call. My name is Clint Tomlinson, and I’ll be your host for tod ...

Call Start: 16:30 January 1, 0000 4:59 PM ET Anavex Life Sciences Corp. (NASDAQ:AVXL) Q4 2021 Earnings Conference Call November 24, 2021, 04:30 PM ET Company Participants Clint Tomlinson - IR Christopher Missling - President & CEO Sandra Boenisch - Principal Financial Officer & Treasurer Conference Call Participants Pete Stavropoulos - Cantor Fitzgeral Soumit Roy - Jones Trading Yun Zhong - BTIG Operator Welcome to the Anavex Life Sciences Fiscal 2021 Fourth Quarter Conference Call. My name is Adrian and I' ...

Call Start: 16:30 January 1, 0000 5:02 PM ET Anavex Life Sciences Corp. (NASDAQ:AVXL) Q3 2021 Earnings Conference Call August 12, 2021 16:30 ET Company Participants Clint Tomlinson - Investor Relations Christopher Missling - President & Chief Executive Officer Sandra Boenisch - Principal Financial Officer & Treasurer Conference Call Participants Soumit Roy - Jones Trading Raghuram Selvaraju - H.C. Wainwright Tom Bishop - BI Research Operator Good afternoon. My name is Adrian and I'll be your conference call ...

Anavex Life Sciences Corp. (NASDAQ:AVXL) Q2 2021 Earnings Conference Call May 13, 2021 2:00 PM ET Company Participants Clint Tomlinson - Investor Relations Christopher Missling - President and Chief Executive Officer Sandra Boenisch - Principal Financial Officer & Treasurer Conference Call Participants Charles Duncan - Cantor Fitzgerald Jeffrey Cohen - Ladenburg Thalmann Raghuram Selvaraju - H.C. Wainwright Tom Bishop - BI Research Clint Tomlinson Thank you and good afternoon, everyone. We appreciate you jo ...